Joica Benschop
Rotterdam, 3023TB, Netherlands
Location status: Recruiting
Location contact
Joica Benschop, MSc
CONTACT
Wendy Oldenmenger, PhD
CONTACT
NCT Number: NCT06350968
The aim of this mixed-methods study is to describe both the implementation process and outcomes of the online module Advance Care Plan for (hemato-)oncology patients within the oncology-network CONCORD.
The main question is: How is implementation and assurance of the advance care plan in daily care for (hemato-)oncological patients within CONCORD achieved, so that early integration of advance care planning in oncological care takes place and patient preferences are discussed?
Healthcare providers and patients are asked to use the module and share their experiences with it.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rotterdam, 3023TB, Netherlands
Location status: Recruiting
Joica Benschop, MSc
CONTACT
Wendy Oldenmenger, PhD
CONTACT
Design Implementation research with a mixed-method design. Population
The implementation of advance care planning should benefit the care of (hemato-)oncology patients aged 18 years and older during the palliative phase of their illness. The research focuses on:
MAIN QUESTION: How is implementation and assurance of the online module advance care planning in daily care for (hemato-)oncological patients within the oncology-network CONCORD achieved, so that early integration of advance care planning in oncological care takes place and patient preferences are discussed? Method
Qualitative research:
Description of the initial situation and the context within each institution, but also of general practitioners and patients using the NASSS Framework. Interviews with project leader, project coordinators in each hospital, healthcare providers from 1st, 2nd and 3rd lines, patients and relatives at the start and end of the project (3-5 in each target group per hospital, taking into account the greatest possible degree of diversity in age, gender and background). At the end of the project, the interviews are repeated to gather information about the experiences and lessons learned and the experiences with facilitating and hindering factors. Each interview is transcribed and analyzed using NVivio or Atlas.ti, analysis programs for qualitative data.
Quantitative research:
EHR-research based on anonymized data using a dashboard. A dashboard is being built in each hospital to analyze data from (hemato-)oncological patients who have been treated in the relevant hospital and have died. The dashboard contains demographic and medical data, the use of the proactive care module and medical consumption in the last three months of their lives.
In each of the participating hospitals, the (hemato-)oncological patients who died in the last 3 months of 2022, 2023, 2024 and 2025 are selected and it will be examined to what extent the advance care plan has been completed and what kind of care the patients have received. A 'Health economic analysis' is carried out using the data from the dashboard. On the one hand, this involves the costs of implementing the advance care planning module used. In addition, the dashboard maps medical consumption in the last three months of life (e.g. ICU admissions, ER visits, clinical admissions, etc.). This is translated into the nationally determined costs for this. This is done both before and after implementation has been mapped out among people who have died, making it possible to gain insight into the difference in costs incurred.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 3 years
Fidelity to the tailored implementation of the ACP-tool
Time frame: 3 years
Healthcare use of patients with cancer in last phase of life (number of hospital admissions, ICU admissions, medication use, etc.)
Time frame: 3 years
Number of filled-in ACP-tools in EHR
Contact information is provided by the study sponsor or research team.
Erasmus Medical Center Oldenmenger, PhD
CONTACT
Joica A.M. Benschop, MSc
CONTACT
Erasmus Medical Center
Other
Acronym: INDEED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07680556
Adenocarcinoma, Behavior
Arnhem, Gelderland, Netherlands
View Trial DetailsNCT06697600
Cancer, Hematologic Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03791073
Digestive System Diseases, Digestive System Neoplasms
Montpellier, France
View Trial DetailsNCT07633236
Cachexia-Anorexia Syndrome, Neoplasms
Moscow, Russia
View Trial Details